Concourse Financial Group Securities, Inc. Coherus Bio Sciences, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$0.72 - $1.12 $0 - $0	0 New	0 $0
Q1 2025 May 14, 2025	BUY	$0.81 - $1.66 $0 - $0	0 New	0 $0
Q4 2024 Feb 13, 2025	BUY	$0.67 - $1.71 $0 - $0	0 New	0 $0
Q3 2024 Oct 10, 2024	BUY	$0.99 - $1.8 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$1.58 - $2.51 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$2.02 - $3.14 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$1.59 - $3.85 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$3.74 - $5.45 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$3.74 - $5.45 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$3.79 - $8.3 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$5.69 - $10.07 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$7.17 - $13.87 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$5.86 - $13.23 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$10.92 - $16.41 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$15.81 - $18.99 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$12.68 - $17.79 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$12.95 - $15.41 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$14.42 - $21.39 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$16.56 - $18.94 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$17.41 - $19.89 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	SELL	$14.43 - $19.16 $1,948 - $2,586	-135 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$11.67 - $22.53 $163 - $315	14 Added 11.57%	135 $2,000
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $1,975 - $2,585	121 New	121 $2,000
Q3 2019 Nov 13, 2019	BUY	$16.3 - $23.37 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$13.1 - $22.1 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$8.38 - $15.5 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.65 - $16.28 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$14.45 - $20.25 $0 - $0	0 New	0 $0

Others Institutions Holding CHRS

# of Institutions

120

Shares Held

56.1M

Call Options Held

89.3K

Put Options Held

31K

Black Rock Inc. New York, NY

11.8M
Shares

$15.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$13.8 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

5.1M
Shares

$6.83 Million
0.22% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$4.07 Million
0.09% of portfolio
Geode Capital Management, LLC Boston, MA

2.68M
Shares

$3.59 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $104M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account